Biopharmas raising money in public or private financings, including: Adverum, Flex Pharma, Fortress, Moderna, PDS Biotechnology, Polarityte, Revance, Revive, Salarius, Theravance, Tonix, Xeris, Zosano.

New hires and promotions in the biopharma industry, including: Axial, Palleon, Sangamo.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Aptorum, Biocryst, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Zai Lab.

Quarterly snapshots from biopharma companies with marketed products, including: Seattle Genetics, Takeda Pharmaceutical.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Astellas Pharma, Ikarovec.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Alterity, Athenex, Aurigene Discovery, Beijing CC-Pharming, Bill & Melinda Gates Foundation, Bridge Biotherapeutics, China Grand, Clover, Curis, Ibio, Oncosec, Porton Pharma Solutions, Q Biomed, Recce.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bluegrass Vascular, Enzo Clinical Labs, Implant Direct, Lucid Diagnostics, Medicrea, Varian.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Clinical Trials Mobile Application.

Med-tech firms raising money in public or private financings, including: Co-Diagnostics, Genomic Vision, Myomo, Rewalk Robotics, Speedx, Stilla Technologies, Transenterix.